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ABSTRACT 
A 1-isopropyl-3-phospholene 1-oxide was prepared and the two enantiomers were isolated 
from the racemate by resolution using optically active TADDOL derivatives or the acidic 
Ca
2+
 salts of (–)-O,O-diaroyl-(2R,3R)-tartaric acids. The single crystal X-ray structure of the 
2 
1-isopropyl-3-phospholene oxide – spiro-TADDOL 1:2 associate revealed the mode of 
binding between the host and guest molecules. The role of the interactions between the three 
molecules was supported not only by the contact data, but also force field and semiempirical 
calculations. Beside X-ray analysis, the absolute configuration of the P-stereogenic center was 
also determined on the basis of CD spectroscopy and high level quantum chemical 
calculations. The racemic and optically active 1-isopropyl-3-phospholenes obtained after 
deoxygenation were converted to the corresponding borane complexes and Pt(II) complexes. 
Stereostructure of the latter species was evaluated by high level quantum chemical 
calculations and the Pt complexes were tested as catalysts in the hydroformylation of styrene. 
Keywords: 
3-Phospholene oxide, Optical resolution, X-ray structure, Theoretical calculations, Pt-
complexes, Hydroformylation 
 
1. Introduction 
The transition metal phosphine complexes are widely used catalysts in homogenous 
catalytic reactions, such as hydrogenation and hydroformylation that underlines the 
importance of phosphines among organophosphorus compounds [1,2]. Among the phosphine 
ligands, the P-stereogenic P(III)-compounds are of great importance. The P-heterocyclic 
derivatives form a special group [3]. However, there are only a few examples in the literature 
for P-heterocyclic phosphines bearing an asymmetric phosphorus atom [4–6]. 
Although an increasing number of examples can be found in the literature for the 
asymmetric syntheses of P-stereogenic compounds [7–9], in most cases the resolution of the 
corresponding racemic compounds is the method of choice for the preparation of optically 
active organophosphorus compounds including P-heterocyclic derivatives with a P-
stereogenic center [6,10]. Many examples can be found in the literature for the resolution of 
3 
cyclic P-chiral phosphines, phosphine oxides and phosphonium salts via the formation of 
covalent diasteromers [11–13], diastereomeric coordination [14–19], molecular complexes 
[10,20,21] or diastereomeric salts [22–27]. 
In the literature, the synthesis of a few optically active P-chiral heterocyclic ligands was 
described and the transition metal complexes of these P(III)-compounds were used as 
catalysts mainly in enantioselective hydrogenation reactions [11,13,16,18,21,28–32]. There 
are only a few examples for P-heterocyclic ligands that were used in hydroformylation [5]. 
Among the transition metal phosphine complexes that can be used as catalyst in 
hydroformylation, the platinum complexes of P-heterocycles form a class that needs further 
investigations. Prigle et al. reported the synthesis of the platinum complexes of several 5-, 6- 
and 7-membered P-heterocycles [33,34]. Gouygou et al. synthesized a few bisphosphole 
platinum-complexes [35]. Recently, our research group contributed to the research of 
optically active P-stereogenic phosphine oxides, as well as to the synthesis of platinum-
complexes incorporating P-chiral heterocyclic ligands. TADDOL-derivatives and the Ca
2+
 
salts of dibenzoyl- and di-p-toluoyl-tartaric acid were applied as the resolving agents to 
prepare the enantiomers of the aryl- and alkyl-3-phospholene oxides [36–42], as well as a few 
six-membered P-heterocyclic phosphine oxides, embracing a 1,2-dihydrophosphinine oxide 
and a 1,2,3,6-tetrahydrophosphinine oxide [43,44]. We have also reported the synthesis of a 
few racemic and optically active borane and platinum-complexes bearing aryl- and alkyl-3-
phospholene ligands. The 3-phospholene - platinum complexes were applied as catalysts in 
the asymmetric hydroformylation of styrene and enantioselectivities up to 29% were obtained 
[45–48]. 
As a continuation of this ongoing research, we wished to proceed with our systematic 
investigation of the resolution of the 3-phospholene oxides. Another aim of ours was to gain a 
deeper understanding how the substituents of the 3-phospholene moiety influence the catalytic 
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activity of the platinum-complexes incorporating 3-phospholene ligands. In this paper, we 
report the synthesis and the resolution of the 1-isopropyl-3-methyl-3-phospholene oxide. The 
1-isopropyl-3-methyl-3-phospholene-borane and platinum complexes were also prepared in 
racemic and optically active forms, and the platinum-complexes were tested as catalysts in the 
hydroformylation of styrene. 
 
2. Results and discussion 
2.1. Synthesis and resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) 
1-Isopropyl-3-methyl-3-phospholene 1-oxide (3) was prepared by extending the synthetic 
method elaborated for other alkyl- and aryl-3-methyl-3-phospholene oxides [37,47,49].  
1-Hydroxy-3-methyl-3-phospholene 1-oxide (1) was reacted with thionyl chloride to form the 
corresponding phosphinic chloride (2) which was immediately reacted with 
isopropylmagnesium bromide to afford 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) in a 
yield of 49%. As a new compound, the isopropyl-phospholene oxide (3) was characterized by 
1
H,
 13
C
 
and
 31
P NMR
 
spectroscopy, as well as HRMS.  
 
 
Scheme 1. 
 
To prepare the enantiomers of isopropyl-phospholene oxide (3), the resolution of racemic 
phosphine oxide 3 was first attempted with TADDOL-derivatives [(−)-4 and (−)-5] that were 
found to be efficient resolving agents for other aryl and alkyl-3-phospholene oxides 
[36,37,40]. 
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A few resolution experiments of isopropyl-phospholene oxide (3) with TADDOL-
derivatives [(−)-4 and (−)-5] were carried out in a mixture of ethyl acetate and hexane. In 
these cases, the mixture of the racemic compound (3) and the given resolving agent [(−)-4 or 
(−)-5] was dissolved in hot ethyl acetate, and the corresponding diastereomer precipitated on 
adding hexane to the reaction mixture.  
Applying alcohols, such as methanol, ethanol or isopropanol as the solvent, the racemic 
compound (3) and the resolving agent [(−)-4 or (−)-5] were dissolved in hot alcohols, and the 
diastereomer appeared by gradually on cooling down the reaction mixture to 26 °C (Scheme 
2).  
In all instances, the corresponding diastereomers were separated from the mother liquor 
by filtration after three hours of crystallization, and they were purified further by two 
recrystallizations. The composition of the corresponding diastereomers was established by 
1
H 
NMR spectroscopy. The enantiomeric mixture of isopropyl-phospholene oxide (3) was 
recovered from the given diastereomer by column chromatography using silica gel and a 97:3 
mixture of dichloromethane and methanol as the eluent. The enantiomeric excess of the 
isopropyl-phospholene oxide (3) was analyzed by chiral GC. 
The results leading to enantiomeric separation of the target molecule 3 were summarized 
in Table 1. Beside the yield and the enantiomeric excess, the resolving capability (S) was also 
determined. The resolving capability (S) is used to describe the overall efficiency of a given 
resolution and this value can be calculated as the product of the yield and the enantiomeric 
excess.  
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Scheme 2. 
 
Applying TADDOL [(−)-4] as the resolving agent for the enantiomeric separation of 3-
phospholene oxide 3, the crystalline diastereomers were obtained in the cases, when ethyl 
acetate/hexane or isopropyl alcohol was used (Table 1, Entries 1 and 2). However, the 
enantiomeric discrimination between the two antipodes of 1-isopropyl-3-phospholene oxide 
(3) was poor in these instances, as the highest enantiomeric excess and resolving capability 
values were 6% and 0.05, respectively (Table 1, Entry 1). It is noteworthy that no 
diastereomeric complex was obtained when methanol or ethanol was used as the solvent, and 
the TADDOL [(−)-4] precipitated exclusively in these instances. 
Applying spiro-TADDOL [(−)-5] as the resolving agent, the enatiomeric excess and the 
resolving capability values were solvent dependent, and the ee was between 57-95%, and the 
resolving capability fell in the range of 0.34-0.47 (Table 1, Entries 3-6). It is noteworthy that 
the solvent also influenced which isopropyl-phospholene oxide (3) enantiomer was 
incorporated into the corresponding diastereomer. (+)-(R)-1-Isopropyl-3-phospholene oxide 
[(+)-3] could be prepared with spiro-TADDOL [(−)-5] in ethyl acetate/hexane or methanol 
(Table 1, Entries 3 and 4). Carrying out the resolution in ethanol or in isopropyl alcohol led to 
the other (−)-(S)-1-isopropyl-3-phospholene oxide antipode [(−)-3] (Table 1, Entries 5 and 6). 
Moreover, the solvent also affected the composition of the diastereomers. A diastereomeric 
complex incorporating isopropyl-phospholene oxide (3) and spiro-TADDOL [(−)-5] in a 1:1 
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ratio was obtained in ethyl acetate/hexane and isopropyl alcohol (Table 1, Entries 3 and 6), 
and the diastereomer having the composition of (3)∙(spiro-TADDOL)2 was separated when 
methanol or ethanol was used as the solvent (Table 1, Entries 4 and 5).  
These results indicated that the TADDOL analogue (−)-5 could be used more efficiently 
for the enantiomeric separation of phosphine oxide 3, than the TADDOL [(−)-4] itself 
(compare Table 1, Entries 1-2 and 3-6). 
 
Table 1. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with TADDOL 
derivatives [(−)-4 and (−)-5] 
Entry Resolving agent  Eq. Solvents
a,b 
Diastereomeric  
complex
c
 
Yield  
(%)
d,g 
ee  
(%)
e,g 
S  
(-)
f,g 
Abs.  
config.
h 
1 TADDOL 0.5 2×EtOAc/10×hexane (3)(TADDOL) 
(98)  
81 
(2)  
6 
(0.02)  
0.05 
(R) 
2 TADDOL 0.5 6×iPrOH (3)(TADDOL) 
(81)  
2* 
(2)  
5* 
(0.02)  
0.00* 
(R) 
3 spiro-TADDOL 0.5 4×EtOAc/10×hexane (3)(spiro-TADDOL) 
(90)  
60 
(35)  
64 
(0.31)  
0.39 
(R) 
4 spiro-TADDOL 1 6×MeOH (3)(spiro-TADDOL)2 
(94)  
60 
(15)  
57 
(0.14)  
0.34 
(R) 
5 spiro-TADDOL 1 6×EtOH (3)(spiro-TADDOL)2 
(88)  
50 
(29)  
95 
(0.26)  
0.47 
(S) 
6 spiro-TADDOL 0.5 6×iPrOH (3)(spiro-TADDOL) 
(84)  
48 
(38)  
89 
(0.32)  
0.43 
(S) 
a
 Mixture of solvents for the crystallization [mL of solvent/g of resolving agent]. 
b  
Mixture of solvents for the recrystallization(s) [mL of solvent/g of resolving agent]. 
c 
The ratio of 3 and (−)-4 or (−)-5 was determined by 1H NMR. 
d 
Based on the half of the racemate 1 that is regarded to be 100% for each antipode. 
e 
Determined by chiral GC. 
f 
Resolving capability, also known as the Fogassy parameter (S = Yield × ee) [50]. 
g 
Results obtained after the first crystallization are shown in “( )”, while results obtained after two 
recrystallizations are shown in boldface. 
h 
The absolute configuration of 3 was determined by X-Ray analysis and CD spectroscopy. 
* Diastereomeric complex was purified with one recrystallization. 
 
The observation that both isopropyl-phospholene oxide antipodes [(+)- and (−)-3] could 
be prepared with the same resolving agent, (spiro-TADDOL [(−)-5]) in different solvents 
allowed us to develop a procedure for the preparation of the (+)- and (−)-isopropyl-
phospholene oxide enantiomers [(+)- and (−)-3] from racemic 3 (Scheme 3). The resolution of 
isopropyl-phospholene oxide 3 utilizing spiro-TADDOL [(−)-5] in ethanol afforded 
8 
diastereomer [(−)-3 ∙ (−)-5] that was purified by three recrystallizations to give the (−)-(S)-1-
isopropyl-3-phospholene oxide [(−)-3] with an ee of 97% and in a yield of 45% after a 
recovery from the diastereomer by column chromatography.  
To prepare (+)-(R)-1-isopropyl-3-phospholene oxide [(+)-3], the mother liquors of the 
crystallization and recrystallizations were combined, and the volatiles were removed to afford 
a mixture of (+)-3 (ee: 23%) and spiro-TADDOL [(−)-5]. To this mixture, a sufficient amount 
of spiro-TADDOL [(−)-5] was added and the resolution was carried out in methanol to obtain 
the (+)-isopropyl-phospholene oxide [(+)-3] with an ee of 87% and in a yield of 40% after 
recrystallizations and decomplexation of the corresponding diastereomer [(+)-3 ∙ (−)-5].  
Besides the methanol, the mixture of ethyl acetate and hexane was also a suitable solvent 
combination to prepare the (+)-(R)-1-isopropyl-3-phospholene oxide [(+)-3] by resolution 
with spiro-TADDOL [(−)-5], as it was indicated by the preliminary experiments (Table 1, 
Entries 3 and 4). Moreover, considering the resolving capability values, the application of 
ethyl acetate/hexane seemed to be more advantageous than methanol (Compare Table 1, 
Entries 3 and 4). However, the purity of the corresponding diastereomer [(+)-3 ∙ (−)-5] could 
not be improved by recrystallizations from ethyl acetate/hexane with the maximum 
diastereomeric excess (de) was 64%. This phenomenon may be explained by the fact that the  
(+)-3 ∙ (−)-5 diastereomer has a eutectic composition at the de of 64%, which hinders the 
purification of this diastereomer. As a consequence, methanol was chosen for the preparation 
of (+)-(R)-1-isopropyl-3-phospholene oxide [(+)-3] by resolution, as it was detailed above. 
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Scheme 3. 
 
Single crystal X-ray structure determination from a proper sample obtained from 
recrystallizations (Table 1, Entry 5), revealed as the most conspicuous feature, also the 1:2 
composition of phospholene oxide (−)-3 and spiro-TADDOL (−)-5 in the asymmetric unit of 
the crystal (Fig. 1).  
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Fig. 1. Atomic displacement representation (50% probability) of the diastereomeric complex 
incorporating (−)-3 and (−)-5 in a ratio of 1:2 in the asymmetric unit with atomic numbering 
and indication of the “classical” O—H...O type H-bridges (in broken lines). 
 
The appearance of two independent hosts in the crystallographic asymmetric units is a 
frequently observed stoichiometry feature in this line of experiments. Two examples from our 
recent studies with 2:2 resolving host – target guest ratio are the 1-butyl-3-methyl-3-
phospholene oxide [40] and the 1-propoxy-3-methyl-3-phospholene oxide [41] guest 
containing crystal structures. This directs attention to the altered stoichiometry from the 
frequently observed 2:2 host/guest ratio. Lately, we expounded the idea of competitive 
resolution [42], where the 2:2 ratio is violated, such that the inclusion of the solvent i-PrOH 
instead of a second phospholene occurred yielding a 1:1:2 guest/solvent/hosts stoichiometry. 
Here we have another case as there is only one (−)-3 guest embedded between two (−)-5 
hosts. It is apparent that the guest is primarily anchored by the H-bridges donated from each 
11 
(−)-5 molecules. Classical H-bonding dimensions (cf. Table 2) are all well defined and 
comply with expectations. The H-bonding pattern retains the well-known internal H-bridge 
structure of the resolving tool, providing a single-donor function only for H-bridging from 
each spiro-TADDOL [(−)-5] host molecules. The double acceptor role of the 3-phospholene 
oxide [(−)-3] ideally uses both lone pair of the O atom. Nevertheless, it is not the classical H-
bridge scheme that delivers surprise. The (−)-3 guest molecule boasts with an unusually large 
number (11) of short C—H...O contacts to the two [(−)-5] molecules of the stoichiometric 
entity (the crystallographic asymmetric unit). In other words, all but one of these contacts are 
of intramolecular (correctly intra-associate) type, 10 out of 11. A closer scrutiny is thus 
warranted. The first step to go ahead is to “normalize” the C—H bond lengths to the “industry 
- standard” 1.08 Å internuclear distance. For comparison Table 2A lists these for the classical 
H-bridges, too, while Table 2B for the less trivial C—H...O ones as well. The emerging 
pattern is also interesting, as almost half of the non-trivial contacts are then eliminated, 5 or 6 
out of 11. These fail to qualify as H-bridge as their D—H...A angles got under 100°. This is 
not so surprising, as the classical H-bridges are nearly linear, so the C—H bond increasing 
will only improve on their geometry. In contrast, the C—H...O contacts are more bent, and in 
cases where the control angle gets under 100° the analysing program drops them from the list. 
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Table 2. Hydrogen Bonds (Å, °) for (−)-1-isopropyl-3-methyl-3-phospholene oxide [(−)-3]. 
The rows beneath each contact (marked “Normalized”) indicate geometry after alteration the 
D—H bond lengths to generally accepted standard distances as shown. 2A) Classical  
O—H...O  H-bridges; 2B) C—H...contact distances 2A) 
2A)      
D—H...A D—H (Å) H...A (Å) D...A (Å) D—H...A (°) Ser. No. 
O2 -- H200 .. O1 0.89(3) 1.85(3) 2.727(2) 172(3) 1 
Normalized 0.98 1.75 2.727(2) 172  
O3 -- H300 .. O2 0.86(3) 1.85(3) 2.705(3) 171(2) 2 
Normalized 0.98 1.73 2.705(3) 170  
O6 -- H600 .. O7 0.85(3) 1.82(3) 2.666(3) 175(3) 3 
Normalized 0.98 1.68 2.666(3) 175  
O7 -- H700 .. O1 0.77(3) 1.90(3) 2.671(2) 176(4) 4 
Normalized 0.98 1.69 2.671(2) 175  
2B)      
C5 -- H5C .. O6i 0.99 2.50 3.307(3) 138 1 
Normalized 1.08 2.44 3.307(3) 136  
C17 -- H17 .. O2 0.99 2.43 2.791(3) 100 2 
- - - - -  
C21 -- H21 .. O4 0.96 2.31 2.967(3) 126 3 
Normalized 1.08 2.23 2.967(3) 123  
C26 -- H26 .. O5 0.99 2.55 3.026(3) 109 4 
Normalized 1.08 2.52 3.026(3) 107  
C30 -- H30 .. O3 0.99 2.42 2.792(3) 101 5 
- - - - -  
C32 -- H32 .. O5 0.96 2.24 2.872(3) 122 6 
Normalized 1.08 2.18 2.872(3) 120  
C49 -- H49 .. O8 0.96 2.51 3.031(3) 114 7 
Normalized 1.08 2.46 3.031(3) 111  
C51 -- H51 .. O7 0.96 2.38 2.729(3) 101 8 
- - - - -  
C64 -- H64 .. O9 1.03 2.33 2.935(3) 116 9 
Normalized 1.08 2.31 2.935(3) 115  
C66 -- H66 .. O6 0.95 2.41 2.768(3) 102 10 
- - - - -  
C70 -- H70 .. O9 1.00 2.58 2.948(3) 101 11 
Normalized 1.08 2.57 2.948(3) 100  
Transformation applied:  i = 1+x,y,z. 
 
Nevertheless, this does not mean that there cannot be other, non-H-bridge interactions 
between such entities. There are, for example, indications that some  
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C—H...Caryl type of short contacts exist. We could just stop here and conclude that the (−)-3 
guest is so tightly bound to its two (−)-5 molecules in their lap that the host conformations 
may not permit inclusion of a second (−)-3 molecule. A full interaction mapping was 
attempted by the aid of program Mercury [51]. The chemical functions defined for the 
mapping were the OH, aryl–CH, and methyl groups. These were used as target interactions in 
the mapping program, and the results are shown in Fig. 2. The “hot spots” can be seen well, 
where interactions of the given kind are the most concentrated. 
 
Fig. 2. A full interaction mapping [51] of the asymmetric unit containing (−)-3 and (−)-5 in a 
ratio of 1:2 in the crystal with (−)-3 in space filling representation. Light contours correspond 
to at least two, while darker more than six contributors. Numbers represent “hot spots” i.e. the 
maximum interaction directions. 
 
It is clear that the dominant hydrophilic interactions roughly match the observed “hot 
spots” in Fig. 2. A further support for the tight encapsulation of (−)-3 comes from the UNI 
intermolecular potential force filed (FF) type calculation [52,53]. 
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Fig. 3. UNI intermolecular potential calculation results [52,53] as implemented in Mercury 
[51] show the two largest lattice contribution in red broken lines to molecule (−)-3 from each 
independent (−)-5 molecule with -50.7 and -48.4 kJ/mol, respectively. 
 
The graphical view (Fig. 3) of the results underlines that the two strongest interactions are 
between (−)-3 and each of the independent (−)-5 molecules in the asymmetric unit, with  
–50.7 and –48.4 kJ/mol. Inter-fragment energies are [(−)-3 and (−)-5I]: −50.7 kJ/mol, [(−)-3 
and (−)-5II]: −48.4 kJ/mol, [(−)-5I and (−)-5II]: −36.4 kJ/mol. A considerable portion  
(−135.5 kJ/mol) of the total of –484 kJ/mol packing energy is thus in the interactions between 
these three molecules of the asymmetric unit. Subsequently, semi-empirical series of 
calculations were also used to assess feasibility of the FF results. These were done by using 
modified PM6 [54] Hamiltonians suggested by Korth (PM6-DH+) [55] and as implemented in 
MOPAC012 [56,57]. The aim was to derive and estimate independently the binding energy of 
(−)-3 to the two molecules of (−)-5 as in the lattice of the associate crystal. The proposed 
strategy for this goal is to use the PM6-DH+ procedure to optimize the geometry of each 
component separately and also to obtain heats of formations for each of them. As FF 
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calculations indicated essential attraction between the two independent (−)-5 molecules a 
change was made such that the geometries were optimized and heat of formation was 
calculated for this assembly of the two spiro-TADDOL molecules. Then the content of the 
asymmetric unit is optimized and the heats of formation are obtained. The binding (or 
intermolecular interaction) energy is then given by  
ΔHB = ΔHF[(−)-3 - (−)-5I - (−)-5II] - ΔHF[(−)-3] – ΔHF[(−)-5I / (−)-5II]. Heats of formations 
components were -1596, -409, -1062 kJ/mol, for [(−)-3 - (−)-5I - (−)-5II], [(−)-3], and for the 
[(−)-5I / (−)-5II] assembly. The resulting binding energy of –125 kJ/mol compares well with 
those obtained from the FF computations. During this procedure basic geometry features, 
such as conservation of H-bridges, etc., were checked and all major features were retained in 
the resulting models. All models converged using default gradients for optimization. A 
modest internal calibration was also provided as ΔHF[(−)-5I] and  
ΔHF[(−)-5II] may be expected to be identical. These were  -480 and –488 kJ/mol [(−)-5I] and 
[(−)-5II], respectively. The less than 2% difference between the ΔHF values would probably be 
a too optimistic estimate of the uncertainty. Nevertheless, the important message is that both 
approaches confirm and similarly quantify the energy background of the geometry conditions 
of binding in the crystal structure, in spite of the more or less differing starting geometries. 
 
Besides the TADDOL-derivatives [(−)-4 and (−)-5], the resolution of 1-isopropyl-3-
methyl-3-phospholene 1-oxide (3) was also attempted with the acidic Ca
2+
 salts of (−)-O,O’-
dibenzoyl- or (−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid [Ca(H-DBTA)2 (−)-6 or Ca(H-
DPTTA)2 (−)-7]. The Ca(H-DBTA)2 [(−)-6] was prepared in advance as described earlier 
[38], whereas the Ca(H-DPTTA)2 [(−)-7] was always formed in situ in the reaction of  
(−)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid and CaO in the mixture of ethanol and water.  
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During the resolution experiments, the given solution of the isopropyl-phospholene oxide 
(3) was added to the hot ethanolic solution of Ca(H-DBTA)2 (−)-6 or Ca(H-DPTTA)2 (−)-7. 
The diastereomers appeared after cooling down the reaction mixture gradually to 26 °C 
(Scheme 4). The crystals were filtered off after 24 h of crystallization and were purified 
further by digestion (i.e. by stirring the diastereomers in the corresponding solvent or solvent 
mixture at 26 °C). The composition of the diastereomers was determined by 1H NMR 
spectroscopy. To obtain the enantiomeric mixture of isopropyl-phospholene oxide (3), the 
crystalline diastereomer was treated with 10% aqueous ammonia and the solution was 
extracted with dichloromethane. The enantiomeric excess of phospholene oxide 3 was 
determined by chiral GC. The results are summarized in Table 3.  
 
 
Scheme 4. 
 
Using Ca(H-DBTA)2 [(−)-6] as the resolving agent, the enantiomeric excess of the (+)-
(R)-1-isopropyl-3-phospholene oxide [(+)-3] fell in the range of 36-48% after one 
recrystallization, and the corresponding diastereomers were obtained in low yields meaning 
resolving capability values of 0.02-0.03 (Table 3, Entries 1-3).  
When Ca(H-DPTTA)2 [(−)-7] was applied as the resolving agent, the enantiomeric excess 
of phospholene oxide 3 was in the range of 85-92% (Table 3, Entries 4-6). Despite the 
promising ee values, the yield of the corresponding diastereomers remained low in all 
instances, when Ca(H-DPTTA)2 [(−)-7] was applied and the corresponding resolving 
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capability values fell in the range of 0.01-0.09 (Table 3, Entries 4-6). It is noteworthy that the 
solvent influenced which isopropyl-phospholene oxide antipode (3) was incorporated into the 
corresponding diastereomer. Applying Ca(H-DPTTA)2 [(−)-7], the (−)-(S)-1-isopropyl-3-
phospholene oxide [(−)-3] could be prepared in a mixture of ethanol and water or in a mixture 
of ethanol, ethyl acetate and water (Table 3, Entries 4 and 5), while the (+)-(R)-1-isopropyl-3-
phospholene oxide [(+)-3] could be obtained in a mixture of ethanol, acetonitrile and water 
(Table 3, Entry 6). 
The results shown in Table 3 indicated that the overall efficiency of resolutions with  
Ca(H-DBTA)2 (−)-6 or Ca(H-DPTTA)2 (−)-7 was considerably lower than those obtained 
with spiro-TADDOL (−)-5 which agent was proved to be the best for the enantiomeric 
separation of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) in our study. 
 
Table 3. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with 0.25 equivalent 
of Ca(H-DBTA)2 [(−)-6] or Ca(H-DPTTA)2 [(−)-7] 
Entry Resolving agent Eq. Solvents
 
Diastereomeric 
complex
c 
Yield  
(%)
d,g 
ee  
(%)
e,g 
S  
(-)
f,g 
Abs. 
config.
h
  
1 Ca(H-DBTA)2 0.25 6×EtOH
a,b
 Ca(3)2(H-DBTA)2 
(33)  
8*
 
(35)  
43*
 
(0.11)  
0.03*
 (R) 
2 Ca(H-DBTA)2 0.25 
3×EtOH/3×EtOAca 
1×EtOH/1×EtOAcb 
Ca(3)2(H-DBTA)2 
(15)  
4* 
(24)  
36* 
(0.04)  
0.02* 
(R) 
3 Ca(H-DBTA)2 0.25 3×EtOH/3×MeCN
a,b
 Ca(3)2(H-DBTA)2 
(49)  
5* 
(44)  
48* 
(0.22)  
0.02* 
(R) 
4 Ca(H-DPTTA)2 0.25 6×EtOH/5% H2O
a,b
 Ca(3)2(H-DPTTA)2 
(50)  
1 
(4)  
90 
(0.02)  
0.01 
(S) 
5 Ca(H-DPTTA)2 0.25 
3×EtOH/3×EtOAc/10% H2O
a
 
1×EtOH/1×EtOAcb 
Ca(3)2(H-DPTTA)2 
(45)  
10 
(46)  
92 
(0.21)  
0.09 
(S) 
6 Ca(H-DPTTA)2 0.25 
3×EtOH/3×MeCN/10% H2O
a
 
1×EtOH/1×MeCNb 
Ca(3)2(H-DPTTA)2 
(44)  
2 
(41)  
85 
(0.18)  
0.02 
(R) 
a
 Mixture of solvents for the crystallization [mL of solvent/g of resolving agent]. 
b  
Mixture of solvents for the recrystallization(s) [mL of solvent/g of resolving agent]. 
c 
The ratio of 3 and (−)-4 or (−)-5 was determined by 1H NMR. 
d 
Based on the half of the racemate 1 that is regarded to be 100% for each antipode. 
e 
Determined by chiral GC. 
f Resolving capability, also known as the Fogassy parameter (S = Yield × ee) [50]. 
g Results obtained after the first crystallization are shown in “( )”, while results obtained after two 
recrystallizations are shown in boldface. 
h 
The absolute configuration of 3 was determined by X-Ray analysis and CD spectroscopy. 
* Diastereomeric complex was purified with one recrystallization.  
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2.2. CD Spectra of the optically active 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) 
The absolute configuration of the title compound (3) was determined by combined 
spectroscopic and theoretical investigations. To compute the spectra of the title compound, 
foremost, a molecular mechanical (MM) conformation analysis was performed for the 
molecule, and 12 stable conformers were found, which lie at most at 10 kJ/mol above the 
lowest energy one. For each of these conformers, the geometry was further optimized at the 
density functional theory (DFT) level, and accurate conformational energies were computed 
using the direct random phase approximation (dRPA) approach. Three low-energy conformers 
were found differing in the orientation of the isopropyl group, two of them are practically 
isoenergetic, whereas the third one lies at around 1.3 kJ/mol below the two others. The 
optimized structure and geometrical parameters for the most stable conformer are presented in 
Fig. 4.  
 
Fig. 4. DFT-optimized geometry for the most stable conformer of phospholene oxide 3 with 
the randomly selected (S) configuration.  Characteristic bond lengths (in Å) and angles (in 
degree) are as follows: P1-O1 1.492, P1-C1 1.838, C1-C2 1.503, C2-C3 1.490, C2-C4 1.335, 
C4-C5 1.496, C5-P1 1.839, P1-C6 1.835, C6-C7 1.525, C6-C8 1.525; O1-P1-C6 113, C1-P1-
C5 95, C1-P1-C6 106, O1-P1-C1 117, O1-P1-C5 117, C5-P1-C6 106, C7-C6-C8 111, C1-C2-
C4 116, C4-C5-P1 104; O1-P1-C6-C7 61, O1-P1-C6-C8 -61, P1-C1-C2-C4 -9, C3-C2-C4-C5 
179. 
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The excitation energies, as well as oscillator and rotator strengths for all the three 
conformers were computed at the time-dependent DFT (TD-DFT) level. The theoretical UV 
absorption and CD curves for each conformer were obtained as superpositions of Gaussian 
functions placed at the wavelengths of the computed transitions with heights proportional to 
the corresponding calculated oscillator (rotator) strengths. The spectra of the conformers were 
Boltzmann-weighted. The averaged spectra were normalized so that the height of the highest 
peak was identical to that of the experimental spectra and were not shifted. The theoretical 
and experimental spectra are presented in Fig 5. 
 
  
a b 
Fig. 5. The calculated (dashed line) UV absorption (a) and CD (b) spectra of (S)-3 with the 
corresponding measured spectra (solid line). 
 
Considering the similarity of the measured and calculated absorption spectra of compound 
3, we can conclude that the selected theoretical methods are adequate. The structure of the 
measured and calculated CD spectra is rather similar. The signs of the dominant peaks in the 
two spectra are identical, and their positions are close to each other. Consequently, the 
absolute configuration of the enantiomer obtained by the resolution (Table 1, Entry 5) is also 
(S), like the configuration of the enantiomer considered in the calculations. 
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2.3. Synthesis of 1-isopropyl-3-methyl-3-phospholene borane and platinum complexes  
(9 and 10) 
First, the racemic and optically active isopropyl-phospholene oxides [3 and (S)-3] were 
deoxygenated with trichlorosilane in separate reactions to obtain the corresponding racemic 
and optically active isopropyl-phospholenes [8 and (R)-8] (Schemes 5 and 6). Deoxygenations 
with trichlorosilane are known to proceed with retention of configuration of the P-stereogenic 
center in case of optically active phosphine oxides. [58]. 
The racemic and optically active 3-phospholenes [8 and (R)-8] so obtained were 
immediately reacted with dimethylsulfide-borane to furnish the corresponding isopropyl-
phospholene-boranes [9 and (R)-9] (Schemes 5 and 6). Beside the synthetic interest, the 
importance of phosphine boranes is demonstrated by the fact that they may be regarded as 
protected phosphines, from which the corresponding P(III)-compounds can be liberated by 
treatment with secondary amines (e.g. diethylamine) [59].
 
The racemic and optically active isopropyl-phospholenes [8 and (R)-8] were also 
converted to the corresponding platinum complexes [cis-10 and cis-(S,S)-10] by reaction with 
dichlorodibenzonitrile platinum. Using racemic isopropyl-phospholene (8) as the starting 
material, the given platinum complex was obtained as a 1:2 mixture of the homo- [cis-(R,R)- 
and cis-(S,S)-10] and the heterochiral isomers [cis-(R,S)-10]. At the same time, application of 
the (R)-1-isopropyl-3-phospholene [(R)-8] afforded the platinum complex exclusively in the 
corresponding homochiral form [cis-(S,S)-10] (Schemes 5 and 6).  
The borane and platinum complexes [9 and 10] of i-propyl-3-phospholene were 
characterized by 
1
H, 
13
C and 
31
P NMR spectroscopy, as well as with HRMS. Due to the 
highly congested spectra of platinum complexes [10 and (S,S)-10], 2D 
1
H-
1
H COSY, 
1
H-
13
C 
HSQC and HMBC experiments were also performed to verify the structure. According to 
expectations, the racemic and optically active platinum complexes [10 and (S,S)-10] contained 
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the 3-phospholene [8 and (R)-8] ligands in cis position that was confirmed by the 
stereospecific 
1
JPt-P coupling constants of 3489 Hz measured for both [10] and [(S,S)-10]. It is 
worth noting that the coupling constants of ca. 3500 Hz are of diagnostic value, and are 
characteristic for those coordinated phosphorus donor atoms possessing the chloro ligand in 
the trans position. The 
13
C NMR spectra of the platinum complexes [10 and (S,S)-10] were 
rather complicated because many signals were split due to 
195
Pt-
13
C and 
31
P-
13
C couplings, 
respectively. The corresponding coupling constants were determined by a first order analysis. 
 
Scheme 5. 
 
 
Scheme 6. 
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Stereostructure of the isopropyl-phospholene - platinum complex (10) was calculated at 
the ωB97X-D/cc-pVTZ//RI-B97-D/6-31G(d) level of theory with cc-pVTZ-PP 
pseudopotential on the Pt atom. Accurate ωB97X-D single point energy calculations 
suggested that the relative energies of the corresponding homochiral [(R,R) and (S,S)] and 
heterochiral (R,S) isopropyl-phospholene - platinum complexes (10) are close to each other 
within 0.6 kcal/mol. The most stable structure of the synthesized cis-bis((S)-1-isopropyl-3-
methyl-3-phospholeno)-dichloro-platinum(II) [(S,S)-10] is displayed in Fig. 6. We found that 
the conformer with rotational symmetry (C2 symmetry group) is the most favourable structure 
which is stabilized by intramolecular nonbonding interactions between the phospholene ring 
and the corresponding alkyl group. The geometry around the Pt atom is considered square 
planar, as the P(1)…Cl(1)…Cl(2)…P(2) pseudo torsion angle is –3.9°. 
The structure of the complexes is determined by nonbonding interaction between the P-
ligands. CH…HC interactions were identified between the C(2)H2 moieties of the two 
phospholene rings (the shortest H...H distance is 2.29 Å) and between the C(2)H2 unit of the 
phospholene ring and the methyl group of the isopropyl substituent of the neighboring 
phospholene moiety (the shortest H…H distance is 2.22 Å, see Fig. 6). These secondary 
interactions also define the environment of the platinum influencing the properties of the 
catalyst. In case of (S,S)-10, one methyl group of each isopropyl substituent is situated, due to 
the C2 symmetry, close to the platinum atom, and it significantly influences the environment 
of the platinum that is shown by the H…Pt…Cl(2)…Cl(1) dihedral angle of 96.1° and the 
H2CH…Pt distance of 3.04 Å (where H is the corresponding proton of one methyl group of 
the isopropyl substituent, See Fig. 6.) 
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Fig. 6. Perspective view of cis-bis((S)-1-isopropyl-3-methyl-3-phospholeno)-dichloro-
platinum(II) [(S,S)-10] calculated by ωB97X-D/cc-pVTZ//RI-B97-D/6-31G(d) method. For Pt 
atoms, cc-pVTZ-PP pseudopotential was applied in all cases. Grey, white grey, orange, green 
and white colours are referred to carbon, hydrogen, phosphorus, chlorine and platinum atoms, 
respectively. Selected bond lengths (Å) and angles (°) are as follows: Pt-Cl(1) 2.402, Pt-P(1) 
2.233, P(1)-C2 1.875, C2-C3 1.520, C3-C4 1.348, C4-C5 1.510, P(1)-C5 1.871, P(1)-C1' 
1.866, C1'-C2' 1.540; Cl(1)-Pt-Cl(2) 90.7, Cl(1)-Pt-P(1) 84.6, Pt-P(1)-C2 121.7, Pt-P(1)-C5 
115.6, Pt-P(1)-C1' 112.0, P(1)-C2-C3 105.3, C2-C3-C4 116.3, C3-C4-C5 118.7, C2-P(1)-C5 
94.2, C2-P(1)-C1' 105.3, C5-P(1)-C1' 105.8, C2'-C1'-C3' 112.4; P(1)…Cl(1)…Cl(2)…P(2)  
–3.9, Cl(1)-Pt-P(1)-C2 161.1, Pt-P(1)-C1'-C3' –55.6, Pt-P(1)-C2-C3 –132.4, P(1)-C2-C3-C4 
6.9, P(1)-C2-C3-CH3 –174.4, C2-C3-C4-C5 –0.5. 
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2.4. Catalytic activity of the 1-isopropyl-3-methyl-3-phospholene - platinum complex in the 
hydroformylation of styrene 
The PtCl2L2-type complexes [cis-10; cis-(S,S)-10] were tested as catalyst precursor in the 
hydroformylation of styrene. The catalysts formed in situ from cis-10 (or cis-(S,S)-10) and 
two equivalents of tin(II) chloride were used under standard ‘oxo-conditions’  
[p(CO) = p(H2) = 40 bar, 100 °C]. As expected in the hydroformylation of styrene, in addition 
to the two types of formyl regioisomers, 2-arylpropanal (A) and 3-arylpropanal (B), 
ethylbenzene (C) as hydrogenation by-product was also formed (Eq. 1). 
PhCH CH2 PhCH(CHO)CH3 + PhCH2CH2CHO + PhCH2CH3
A B    C
CO/H2
               (1) 
 
The catalytic system is active at a temperature as low as 40 °C. Considering the 
conversions obtained with similar catalysts but containing P-alkyl-phospholenes and 
phospholanes,[46] the catalytic activity was rather low. 
The formation of the aldehydes (A and B) was preferred in all cases and 
chemoselectivities up to 93% were obtained. Slight increase in aldehyde selectivity was 
observed by increasing the reaction temperature (Table 4, Entries 1-3).  
As regards the regioselectivity, the influence of the structure of the catalyst is even more 
pronounced. The branched aldehyde (A) predominated, when the ligand was used in racemic 
form, i.e., the catalyst precursor was a mixture of homo- and heterochiral forms ((R,R)-10, 
(S,S)-10, (R,S)-10). A lower regioselectivity was observed, when the ligand was used in 
enantiomerically pure form, i.e., the catalyst precursor was a homochiral complex ((S,S)-10). 
For instance, 73% and 49% regioselectivities were obtained at 100 °C, when racemic and 
enantiomerically pure ligands were used, respectively (Compare for instance entries 3 and 6). 
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A similar change in regioselectivity was observed at 40 °C and 60 °C (entries 1, 4 and 2, 5, 
respectively). 
The explanation for the above phenomenon might be based on the different structure and 
reactivity of the diastereomeric transition states coordinating the substrate. The transition state 
complexes, coordinating the prochiral alkene (styrene) either to (S,S)-10 or (S,R)-10, reveal 
different reactivity towards alkene migratory insertion. Consequently, the ratio of the 
platinum(II)-branched alkyl intermediate to the corresponding linear alkyl intermediate might 
be different in case of homochiral and heterochiral complexes. If we suppose that the 
stereochemical outcome of the reaction is decided in this step (and not in the following CO-
insertion step), the unexpectedly large difference in regioselectivities can be rationalized. 
Enantioselective hydroformylation only with low ee-s could be performed when the 
complex (S,S)-10 was used. The temperature-dependence of the ee-s is not pronounced. 
 
Table 4. Hydroformylation of styrene in the presence of in situ formed catalysts from cis-
PtCl2(L)2 complex [cis-10; cis-(S,S)-10] and tin(II) chloride
a
 
Entry L Temp. (°C) R. time (h) Conv. (%) Rc 
b
 (%) Rbr 
c
 (%) e.e.
d
 (%) 
1 8 40 96 28 73 89 - 
2 8 60 72 30 87 77 - 
3 8 100 24 65 91 73 - 
4 (R)-8 40 96 24 84 69 7 (S) 
5 (R)-8 60 72 27 90 52 10 (S) 
6 (R)-8 100 24 85 93 49 10 (S) 
A: 2-phenylpropanal, B: 3-phenylpropanal, C: ethylbenzene. 
a 
Reaction conditions: Pt/styrene = 1/100, Pt/SnCl2 = 1/2; p(CO) = p(H2) = 40 bar, 1 mmol of styrene, 
solvent: 10 mL of toluene. 
b 
Chemoselectivity towards aldehydes (A, B). [(moles of A + moles of B)/(moles of A + moles of B + 
moles of C) × 100]. 
c 
Regioselectivity towards branched aldehyde (A). [moles of A/(moles of A + moles of B) × 100]. 
 
3. Conclusions 
The family of optically active 3-methyl-3-phospholene oxides was expanded by the 
enantiomers of 1-isopropyl derivative. The optical resolution of the racemate was performed 
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in different ways applying either TADDOL derivatives, or the acidic Ca
2+
 salts of (–)-O,O’-
diaroyl-(2R,3R)-tartaric acids. In one case, the diastereomer associate could be analyzed by X-
ray chrystallography. The stochiometry of the associate and the stabilizing intermolecular 
contacts between the guest and the two host molecules were evaluated. The absolute 
configuration of the P-stereogenic center was also confirmed by CD spectroscopy and 
quantum chemical calculations. The racemic and optically active P-ligands obtained after 
deoxygenation were converted to the corresponding borane and platinum(II) complexes. 
Stereostructure of the latter PtL2Cl2 species (where L=isopropyl-3-methyl-3-phospholene) 
was evaluated by high level calculations and they were tested as catalyst in the 
hydroformylation of styrene. 
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4. Experimental 
4.1. General (instruments) 
The 
31
P NMR spectra were recorded on a Bruker AV-300 spectrometer operating at 121.5 
MHz, while the 
13
C and 
1
H NMR spectra were obtained on a Bruker DRX-500 spectrometer 
operating at 125.7 and 500 MHz, respectively. 2D 
1
H-
1
H COSY, 
1
H-
13
C HSQC and HMBC 
spectra of platinum complexes [10 and (S,S)-10] were acquired on a Bruker Avance II 
spectrometer operating at 500 MHz 
1
H frequency equipped with a BBI or a TXI z-gradient 
probe. The couplings are given in Hz. The exact mass measurements were performed using a 
Q-TOF Premier mass spectrometer in positive electrospray mode. The enantiomeric excess 
(ee) values of the phospholene oxide 3 were determined by chiral GC on Agilent 4890D 
instrument equipped with a GAMMA DEX
TM
 120 column (30 m × 0.25 mm, 0.25 μm film, 
FID detector, nitrogen as carrier gas, injector 240 °C, detector 300 °C, head pressure: 10 psi, 
at 1:100 split ratio). Retention times of 3 by chiral GC (program: 40 min at 150 °C):  
30.2 min for (R)-3 and 30.9 min for (S)-3. The determination of the ee-s of 2-phenylpropanal 
(A) was carried out on Thermo Scientific FOCUS gas-chromatograph equipped with a 
Cyclodex column (20 m × 0.25 mm, 0.25 μm film, FID detector, helium as carrier gas, 
injector 250 °C, detector 280 °C, head pressure: 14.5 psi). (S)-2-Phenylpropanal was eluted 
before the (R)-enantiomer. Optical rotations were determined on a Perkin-Elmer 241 
polarimeter. 
The (−)-(4R,5R)-4,5-bis(diphenylhydroxymethyl)-2,2-dimethyldioxolane [(−)-4],  
the (–)-(2R,3R)-α,α,α’,α’-tetraphenyl-1,4-dioxaspiro[4.5]decan-2,3-dimethanol [(−)-5] and the 
calcium hydrogen (−)-O,O’-dibezoyl-(2R,3R)-tartrate [(−)-6] were synthesized as described 
earlier. (−)-O,O’-Dibezoyl- and (–)-O,O’-di-p-toluoyl-(2R,3R)-tartaric acid were purchased 
from Aldrich Chemical Co. 
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4.2. Preparation of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) 
To 14.1 g (106.4 mmol) of 1-hydroxy-3-phospholene 1-oxide (1) in 60 mL of chloroform 
was added 10.1 mL (138.4 mmol) of thionyl chloride and the solution was stirred overnight. 
The volatile components were removed in vacuo, and the residue was dissolved in 70 mL of 
THF. To the solution so obtained was added dropwise 159.7 mmol of isopropylmagnesium 
bromide in 90 mL of THF (prepared from 4.1 g (167.7 mmol) of magnesium and 15 mL 
(159.7 mmol) of isopropyl bromide) at 0 °C, and the mixture was stirred overnight. The 
mixture was then quenched with a 3M HCl at 0 °C. The two phases were separated, and the 
organic layer was washed with NaHCO3, brine and then dried (Na2SO4). After evaporating the 
solvent, the residue so obtained was purified by column chromatography (silica gel, 3% 
methanol in dichloromethane) to give 8.2 g (49%) of 1-isopropyl-3-methyl-3-phospholene 1-
oxide (3) as a dense oil. 
1
H NMR (CDCl3) δ 1.20 (dd, J = 2.2, 7.2, 3H) and 1.23 (dd, J = 2.2, 7.1, 3H) CH(CH3)2, 
1.79 (bs, 3H, C3-CH3), 1.95-2.05 (m, 1H, CH(CH3)2), 2.38-2.52 (m, 4H, CH2PCH2), 5.49 (m, 
1H, CH=); 
13
C NMR (CDCl3) δ 15.5 and 15.6 (CH(CH3)2), 20.3 (
3
JP-C = 10, C3-CH3), 28.4 
(
1
JP-C = 64, C1’), 30.4 (
1
JP-C = 61, C5), 33.5 (
1
JP-C = 64, C2), 121.2 (
2
JP-C = 7, C4), 137.1 (
2
JP-C 
= 12, C3); 
31
P NMR (CDCl3) δ 76.0; HRMS [M+H]
+
found = 159.0934, C8H16OP requires 
158.0861. 
 
4.3. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with TADDOL [(−)-4] 
(Representative Procedure I.) 
0.15 g (0.95 mmol) of racemic 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) and 0.22 
g (0.48 mmol) of TADDOL [(−)-4] was dissolved in 0.44 mL of hot ethyl acetate, and then  
2.2 mL of hexane was added. Colourless crystalline diastereomeric complex (R)-
3∙(TADDOL) appeared immediately. After standing at 26 °C for 3 h, the crystals were 
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separated by filtration to give 0.29 g (98%) of (R)-3∙(TADDOL) with a de of 2%. The 
diastereomeric complex (R)-3∙(TADDOL) was purified further by two recrystallizations from 
a mixture of 0.44 mL of ethyl acetate and 2.2 mL of hexane to afford 0.25 g (84%) of the 
complex (R)-3∙(TADDOL) with a de of 6%. The (R)-1-isopropyl-3-methyl-3-phospholene 1-
oxide [(R)-3] was recovered from the diastereomer by column chromatography (silica gel, 
dichloromethane-methanol 97:3) to give 0.061 g (81%) of phospholene oxide (R)-3 with an ee 
of 6% (Table 1, Entry 1). Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with 
TADDOL [(−)-4] was also performed using isopropyl alcohol. In this instance, the racemic 
isopropyl-phospholene oxide 3 and the TADDOL [(−)-4] were dissolved in hot isopropyl 
alcohol, and the corresponding diastereomeric complex [(R)-3∙(TADDOL)] precipitated by 
cooling the mixture to 26 °C (Table 1, Entry 2). 
 
4.4. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with spiro-TADDOL  
[(−)-5]  
The resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with spiro-TADDOL 
[(−)-5] was carried out according to Representative Procedure I. The conditions and the 
results are shown in Table 1, Entries 3–6. 
 
4.5. Preparation of both enantiomers of 1-isopropyl-3-methyl-3-phospholene 1-oxide  
[(S)- and (R)-3] with spiro-TADDOL [(−)-5] 
The (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] was obtained by the 
resolution of 0.71 g (4.5 mmol) of racemic 3 with 2.3 g (4.5 mmol) of spiro-TADDOL [(−)-5] 
in 13.6 mL of ethanol according to Representative Procedure I. The diastereomeric complex  
[(S)-3∙(spiro-TADDOL)2] was purified by three recrystallizations in 13.6 mL of ethanol. The 
(S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] was recovered by column 
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chromatography (silica gel, dichloromethane-methanol 97:3) to give 0.16 g (45%) of (S)-3 in 
an ee of 97% [  25D = −12.8 (c 0.8, CHCl3)]. The mother liquors of the crystallization and 
recrystallizations were combined, and the solvent was evaporated to afford 1.71 g (150%) of a 
white powder as a 1:0.69 mixture of (R)-3 with an ee of 23% and spiro-TADDOL [(−)-5]. 
0.91 g (1.8 mmol) of spiro-TADDOL [(−)-5] was added to this mixture and the resolution was 
performed in 11.5 mL of methanol according to Representative Procedure I. The [(R)-
3∙(spiro-TADDOL)2] complex was purified by two recrystallizations in 11.5 mL of methanol 
and it was decomposed by column chromatography (silica gel, dichloromethane-methanol 
97:3) to give 0.14 g (40%) of (R)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(R)-3] in an 
ee of 87%. 
 
4.6. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with calcium hydrogen 
O,O’-dibenzoyl-(2R,3R)-tartrate [(−)-6] (Representative Procedure II.) 
To 0.14 g (0.17 mmol) of Ca(H-DBTA)2∙(H2O)2 [(−)-6∙(H2O)2] in 0.40 mL of hot ethanol 
was added 0.11 g (0.69 mmol) of racemic 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) in  
0.40 mL of ethanol. After the addition, the solution was allowed to cool to 26 °C, whereupon 
colourless crystals appeared. After standing at 26 °C for 24 h, the crystals were filtered off to 
give 0.60 g (33%) of Ca[((R)-3)2(H-DBTA)2] with a de of 35%. The diastereomeric complex 
was purified further by one digestion, by stirring the suspension of the diastereomeric 
complex at 26 °C in 0.80 mL of ethanol for 24 h to give 0.022 g (12%) of  
Ca[((R)-3)2(H-DBTA)2] with a de of 43%. The (R)-1-isopropyl-3-methyl-3-phospholene 1-
oxide [(R)-3] was recovered from the diastereomeric complex by treatment of the 2 mL 
dichloromethane suspension of Ca[((R)-3)2(H-DBTA)2] with 2 mL of a 10% aqueous 
ammonia. The organic layer was washed with 0.5 mL of water, dried (Na2SO4), and 
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concentrated to give 0.004 g (8%) of (R)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(R)-3] 
with an ee of 43% (Table 3, Entry 1).  
Resolution of isopropyl-3-methyl-3-phospholene 1-oxide (3) with Ca(H-DBTA)2 [(−)-6] 
was also performed in a mixture of ethanol and ethyl acetate and that of ethanol and 
acetonitrile according to Representative Procedure II. The conditions and the results are 
shown in Table 3, Entries 2 and 3. 
 
4.7. Resolution of 1-isopropyl-3-methyl-3-phospholene 1-oxide (3) with calcium hydrogen 
O,O’-di-p-toluoyl-(2R,3R)-tartrate [(−)-7] (Representative Procedure III.) 
To 0.19 g (0.48 mmol) of DPTTA∙H2O in a mixture of 0.60 mL of ethanol and 0.06 mL of 
water was added 0.014 g (0.24 mmol) of CaO, and the mixture was heated at the boiling point 
until it became clear. 0.15 g (0.97 mmol) of racemic 1-isopropyl-3-methyl-3-phospholene 1-
oxide (3) in 0.60 mL of ethyl acetate was then added to the solution of the in situ formed 
resolving agent Ca(H-DPTTA)2 [(−)-7]. After the addition, the solution was allowed to cool 
down to 26 °C, whereupon colourless crystals appeared. After standing at 26 °C for 24 h, the 
crystals were filtered off to give 0.12 g (45%) of Ca[((S)-3)2(H-DPTTA)2] with a de of 46%. 
The diastereomeric complex was purified further by two digestions, by stirring the suspension 
of the diastereomeric complex at 26 °C for 24 h in a mixture of 0.60 mL of ethanol and 0.60 
mL of ethyl acetate to give 0.038 g (14%) Ca[((S)-3)2(H-DPTTA)2] with a de of 92%.  
The (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] was recovered from the 
corresponding diastereomeric complex similarly to the procedure described in Section 4.6 to 
afford 0.008 g (10%) of (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] with an ee of 
92% (Table 3, Entry 5). 
Resolution of isopropyl-3-methyl-3-phospholene 1-oxide (3) with Ca(H-DPTTA)2 [(−)-7] 
was also performed in a mixture of ethanol and water and that of ethanol, water and 
32 
acetonitrile according to Representative Procedure III. The conditions and the results are 
shown in Table 3, Entries 4 and 6. 
 
4.8. Preparation of 1-isopropyl-3-methyl-3-phospholene-borane (9) 
The solution of 0.11 g (0.68 mmol) of racemic 1-isopropyl-3-methyl-3-phospholene 1-
oxide (3) in 2 mL of toluene was degassed and cooled to 0 °C, then 0.56 mL (4.1 mmol) of 
trichlorosilane was added. The mixture was stirred at 0 °C for 3 h and then at 26 °C for 3 h 
under nitrogen to afford the corresponding phospholene (8) that was immediately reacted 
further. 0.34 mL of 2 M dimethyl sulfide borane in tetrahydrofuran (0.68 mmol) was added 
and the solution was stirred at 26 °C for 3 h under nitrogen. Then, the mixture was treated 
with 3 mL of water and stirred for 15 min. The precipitated boric acid was removed by 
filtration and the organic phase dried (Na2SO4). Volatile components were removed under 
reduced pressure and the residue so obtained was purified by column chromatography (silica 
gel, 3% methanol in dichloromethane) to give 0.041 g (38%) of 1-isopropyl-3-methyl-3-
phospholene-borane (9). 
1
H NMR (CDCl3) δ 0.35-1.04 (m, 3H, BH3), δ 1.12 (d, J = 7.1, 3H) 
and 1.18 (d, J = 7.1, 3H) CH(CH3)2, 1.80 (bs, 3H, C3-CH3), 1.84-1.97 (m, 1H, CH(CH3)2), 
2.34-2.56 (m, 4H, CH2PCH2), 5.43 (m, 1H, CH=); 
13
C NMR (CDCl3) δ 16.6 and 16.7 
CH(CH3)2, 19.1 (
3
JP-C = 7, C3-CH3), 24.1 (
1
JP-C = 31, C1’), 28.4 (
1
JP-C = 33, C5), 32.2 (
1
JP-C = 
35, C2), 122.2 (C4), 138.2 (
2
JP-C = 3, C3);
 31
P NMR (CDCl3) δ 42.9 (broad); [M+Na]
+
found = 
179.1134, C8H18PBNa requires 179.1131 for the 
11
B isotope. 
 
The optically active (R)-1-isopropyl-3-methyl-3-phospholene-borane [(R)-9] was prepared 
in a similar manner from (S)-1-isopropyl-3-methyl-3-phospholene 1-oxide [(S)-3] with an ee 
of 97%. Yield of (R)-9: 40%; 
1
H NMR (CDCl3) δ 0.40-1.05 (m, 3H, BH3), δ 1.12 (d, J = 7.0, 
3H) and 1.18 (d, J = 7.0, 3H) CH(CH3)2, 1.80 (bs, 3H, C3-CH3), 1.86-1.97 (m, 1H, 
33 
CH(CH3)2), 2.32-2.55 (m, 4H, CH2PCH2), 5.43 (m, 1H, CH=); 
13
C NMR (CDCl3) δ 16.6 and 
16.7 CH(CH3)2, 19.2 (
3
JP-C = 7, C3-CH3), 24.0 (
1
JP-C = 31, C1’), 28.4 (
1
JP-C = 33, C5), 32.1 (
1
JP-
C = 35, C2), 122.2 (C4), 138.2 (
2
JP-C = 3, C3);
 31
P NMR (CDCl3) δ 43.2 (broad); [  25D = +3.8 
(c 1, CHCl3)]. 
 
4.9. Preparation of cis-[bis(1-isopropyl-3-methyl-3-phospholeno)-dichloro-platinum(II)] (10) 
The deoxygenation of 0.067 g (0.43 mmol) of racemic 1-isopropyl-3-methyl-3-
phospholene 1-oxide (3) was carried out in benzene using 0.26 mL (2.6 mmol) of 
trichlorosilane according to the procedure described in Section 4.8. Then, 0.10 g (0.21 mmol) 
of dichlorodibenzonitrile-platinum(II) was added to the reaction mixture under nitrogen. The 
mixture was stirred at 26 °C for 1 day, whereupon the complex precipitated. Separation by 
filtration led to 0.10 g (87%) of 10 as a 2:1 mixture of the hetero- (R,S) and homochiral [(R,R) 
and (S,S)] forms. 
1
H NMR (CDCl3) δ 1.13-1.24 (m, 12H, CH(CH3)2), 1.81 (bs, 6H, C3-CH3), 
2.51-2.63 (m, 2H, CH(CH3)2), 2.74-3.12 (m, 8H, CH2PCH2), 5.47 (m, 2H, CH=); 
13
C NMR 
(CDCl3) δ 17.8-17.9 (m) and 18.1-18.3 (m) CH(CH3)2 of the homochiral form, 17.9-18.1 (m, 
CH(CH3)2 of the heterochiral form), 18.8-18.9 (m, C3-CH3), 27.7-28.1 (m, C1’), 30.5-31.2 (m, 
C5), 34.4-35.0 (m, C2), 122.7 (
3
JPt-C = cannot be observed, C4 of the homochiral form), 122.9 
(
3
JPt-C = 29, C4 of the heterochiral form), 138.9-139.0 (m, C3 of the heterochiral form), 139.2-
139.3 (m, C3 of the homochiral form);
 31
P NMR (CDCl3) δ 29.7 (
1
JPt-P = 3489); HRMS [M–
Cl]
+
found = 513.1146, C16H30P2ClPt requires 513.1138 for the 
35
Cl and 
195
Pt isotopes. 
 
The optically active cis-[bis-(S)- 1-isopropyl-3-methyl-3-phospholeno)-dichloro-
platinum(II)] [(S,S)-10] was prepared in a similar manner from (S)-1-isopropyl-3-methyl-3-
phospholene 1-oxide [(S)-3] with an ee of 97%. Yield of (R)-9: 75%.  
25
D = +18.8 (c 1, 
CHCl3); 
1
H NMR (CDCl3) δ 1.15 (dd, 
3
JH-H = 7.1, 
3
JP-H = 16.7, 6H, CH(CH3)2), 1.18 (dd, 
3
JH-
34 
H = 7.2, 
3
JP-H = 17.2, 6H, CH(CH3)2), 1.79 (bs, 6H, C3-CH3), 2.48-2.58 (m, 2H, CH(CH3)2), 
2.77-2.89 (m, 6H, CH2PCH2), 2.95-3.10 (m, 2H, CH2PCH2), 5.44 (m, 2H, CH=); 
13
C NMR 
(CDCl3) δ 17.8 (
3
J Pt-C = 22) and 18.2 (
3
J Pt-C = 20) CH(CH3)2, 18.8 (
4
JPt-C = 33, 
3
JP-C = 4, 
5
JP-C 
= 4, C3-CH3), 27.9 (
2
JPt-C = 31, 
1
JP-C = 40, 
3
JP-C = 6, C1’), 30.7 (
2
JPt-C = 54, 
1
JP-C = 42, 
3
JP-C = 
4, C5), 34.8 (
2
JPt-C = 46, 
1
JP-C = 46, 
3
JP-C = 4, C2), 122.7 (
3
JPt-C = 26, C4), 139.2 (
3
JPt-C = 28, 
C3);
 31
P NMR (CDCl3) δ 29.7 (
1
JPt-P = 3489); HRMS [M–Cl]
+
found = 513.1129, C16H30P2ClPt 
requires 513.1138 for the 
35
Cl and 
195
Pt isotopes. 
 
4.10. Hydroformylation experiments 
In a typical experiment, a solution of PtCl2(ligand)2 (10 or (S,S)-10, 5.5 mg, 0.01 mmol) 
and tin(II) chloride (3.8 mg; 0.02 mmol) in toluene (10 mL) containing styrene (0.115 mL, 1.0 
mmol) was transferred under argon into a 100 mL stainless steel autoclave. The reaction 
vessel was pressurized to 80 bar total pressure (CO/H2 = 1:1) and placed in an oil bath of 
constant temperature. The mixture was stirred with a magnetic stirrer for the given reaction 
time. The pressure was monitored throughout the reaction. After cooling and venting of the 
autoclave, the pale yellow solution was removed and immediately analyzed by GC, chiral GC 
(on a capillary Cyclodex column, (R)-2-phenylpropanal was eluted before the (S) enantiomer) 
and GC-MS. 
 
4.11. X-Ray measurements 
A crystal of the diastereomeric complex incorporating (−)-3 and (−)-5 in a ratio of 1 : 2 
was mounted on a glass fibre. Cell parameters were determined by least-squares from the 
respective setting angles as quoted. Completeness were equal or greater to 2θ = 99.5%. Multi-
scan absorption correction was applied to the data with minimum and maximum transmission 
factors of 0.965 and 0.992. Initial structure models were obtained by direct methods [60] and 
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subsequent difference syntheses. Anisotropic full-matrix least-squares refinement on F2 were 
applied [60] for all non-hydrogen atoms and the model was refined to convergence. Hydrogen 
atomic positions were calculated from assumed geometries where appropriate. Four O—H 
hydrogen atoms were located from difference electron density maps. Hydrogen atoms were 
included in structure factor calculations and the non-trivial hydrogen positions and their 
isotropic displacements were refined. Other H atoms were kept riding on their anchor atoms, 
with isotropic displacement parameters of these hydrogen atoms were approximated from the 
U(eq) value of the atom they were bonded. The maximum and minimum residual electron 
densities in the final difference maps are 0.19 and –0.23 e.Å–3 and are normal. All further 
calculations and drawings were done by using PLATON [61], Mercury [51] and SCHAKAL 
[62]. Crystal structure data are deposited with the Cambridge Crystallographic Data Centre 
under CCDC 1405185 and can be obtained free of charge upon application. 
 
4.12. CD spectroscopy 
The UV and CD spectra were measured in acetonitrile solutions at 25 °C. The UV spectra 
were recorded on an Agilent 8453 diode array spectrometer. The CD spectra were taken on a 
Jasco J-810 spectropolarimeter. 
The Marvin [63], Gaussian 09 [64], and MRCC [65] packages were used for the MM, 
DFT, and dRPA calculations. In the MM conformational analysis, the MMFF [66] force field 
was applied. The geometry optimizations were carried out at the DFT level using the PBE0 
[67,68] functional and the aug-cc-pVTZ [69] basis set. For the calculations of the absorption 
and CD spectra, a time-dependent DFT (TD-DFT) [70] method was used with the same 
functional and basis set. Rotator strengths were calculated in the velocity gauge. To mimic the 
experimental conditions all the DFT calculations were performed using the polarized 
continuum model (PCM) [71] with acetonitrile as the solvent. The dRPA energies were 
36 
computed with the aug-cc-pVTZ basis set and PBE0 orbitals. To calculate the 298 K Gibbs 
energies of the conformers in the solvent, the gas-phase dRPA energies were adjusted by 
temperature corrections, entropy contributions, and Gibbs energies of solvation evaluated at 
the DFT level. 
 
4.13. Theoretical calculations 
Geometries were computed at the RI-B97-D/6-31G(d) level of theory [72–75] then single 
point energy calculations were performed at the optima using ωB97X-D/cc-pVTZ level 
[76,77]. For Pt atoms, cc-pVTZ-PP pseudopotential [78] was applied for both geometry 
optimization and single point energy calculations. Minima on the potential energy surface 
(PES) were characterized by harmonic vibrational frequency calculations. Calculations were 
carried out using Gaussian09 [64] program. Avogadro was utilized for visualization [79]. 
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